IMMEDIATE RESULTS OF DELAYED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME

Objective. Percutaneous coronary interventions (PCI) have long been an effective tool in the treatment of acute coronary syndromes (ACS), and timely interventions in such patients have great importance. However, due to socio-economic difficulties, it is not always possible to treat adequately this acute condition, in accordance with established international criteria. This gives an opportunity to investigate the results of the practical approach to delayed percutaneous coronary interventions in patients with acute coronary syndrome.

Purpose. Evaluate the immediate results of delayed percutaneous coronary interventions in patients with acute coronary syndrome.

Methods. In this study were included patients with ACS who received coronary angiography with stenting of coronary arteries («acute» PCI group, 42 patients), patients who were treated by medical therapy for ACS in the hospital without possibility of PCI (50 patients), and medically stabilized patients after ACS, which were given for angiography and PCI. (average, 30 days after ACS, 49 patients). The groups did not differ in basic demographic and clinical characteristics. Standard clinical, electrocardiographic (ECG) and echocardiographic (ECH0) data were evaluated.

Results. In the PCI groups, angiographic success was achieved in 100%. The average time from the symptoms onset to PCI in the «acute» group was 89.4 hours. In the «acute» group, mortality was 3 patients (7.1%), and in the medical therapy group, mortality was 18% (p <0,05). In the «acute» group two patients had cardiac adverse events, and at presented they had a cardiogenic shock symptoms, one patient died from complications due to major bleeding. The positive dynamics of ST segment recovery on the ECG and ECH0 parameters was more pronounced in the «acute» PCI group.

Conclusions. Despite on the time delay, PCI in ACS is more effective method of restoring myocardial function even in comparison with patients who received early thrombolysis.

1. Steg P.G., James S.K., Atar D. et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33(20):2569-619.;

2. Gershlick A.H., Banning A.P., Myat A. et al. Reperfusion therapy for STEMI: is there still a role for thrombolysis in the era of primary percutaneous coronary intervention? Lancet 2013; 382(9892):624-32.

3. Boersma E., Maas A.C., Deckers J.W., Simoons M.L. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996; 348(9030):771-5.

4. Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 2006; 27(7):779-88.

5. Keeley E.C., Boura J.A., Grines C.L. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials. Lancet 2006; 367(9510):579-88.

6. Mehilli J., Kastrati A, Schulz S. et al. Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial. Circulation 2009; 119(14):1933-40.

7. Busk M., Kaltoft A., Nielsen S.S. et al. Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for ,12 h vs. 12-72 h. Eur Heart J 2009; 30(11):1322-30.

8. Schomig A., Mehilli J., Antoniucci D. et al. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA 2005; 293(23):2865-72.

9. Herrin J., Miller L.E., Turkmani D.F. et al. National performance on door-in to door-out time among patients transferred for primary percutaneous coronary intervention. Arch Intern Med 2011; 171(21):1879-86.

10. Wang T.Y., Nallamothu B.K., Krumholz H.M. et al. Association of door-in to door-out time with reperfusion delays and outcomes among patients transferred for primary percutaneous coronary intervention. JAMA 2011; 305(24):2540-7.

11. ESC/EACTS recommendations on myocardial revascularization 2014. Russian Cardiology Journal 2015; 2(118): 27-28 [in Russian].

12. McLaughlin M.G., Stone G.W., Aymong E. et al. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol. 2004; 44:1215-1223

13. Vakili H., Sadeghi R., Rezapoor P., Gachkar L. In-hospital outcomes after primary percutaneous coronary intervention according to left ventricular ejection fraction. ARYA Atheroscler 2014; 10(4): 211-7.